Arrhythmogenic right ventricular cardiomyopathy/dysplasia is an inheritable heart muscle disease with a natural history that is related predominantly to sudden death, mostly in young people. There is general agreement that an implantable cardioverter-defibrillator (ICD) is indicated in arrhythmogenic right ventricular cardiomyopathy/dysplasia patients who survived an episode of ventricular fibrillation or sustained ventricular tachycardia, whereas prophylactic ICD therapy in patients with no history of sustained tachyarrhythmias or cardiac arrest is still an unsolved issue. There is a tendency to implant an ICD once the disease has been diagnosed, regardless of symptoms or life-threatening ventricular arrhythmias. Hence, a growing cohort of young arrhythmogenic right ventricular cardiomyopathy/dysplasia patients such as asymptomatic relatives and healthy gene carriers who are identified by cascade family screening may undergo unnecessary ICD implantations with significant economic costs and quality-of-life concerns. The present multicenter study assessed the long-term outcome and determinants of ICD therapy in a large arrhythmogenic right ventricular cardiomyopathy/dysplasia population with no prior ventricular fibrillation or sustained ventricular tachycardia. The study results suggest that ICD implantation is as necessary in patients with a history of syncope as it is in those who suffer arrhythmic cardiac arrest. However, prophylactic ICD implantation may not be justified in asymptomatic patients regardless of family history of sudden death or results of programmed ventricular stimulation because of their favorable long-term outcome. Programmed ventricular stimulation, traditionally used to stratify the risk of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients without spontaneous ventricular tachyarrhythmias, is of limited value in predicting appropriate ICD interventions and should not be used as a routine prognostic strategy. See p 1144.
Spectrum and Outcome of Reoperations After the Ross Procedure
Although this manuscript deals with a topic that is surgical in nature, it also provides valuable information to cardiologists, because they are involved in the preoperative consultation and the long-term follow-up of patients being considered for the Ross procedure. The Ross procedure is performed for aortic valve disease and is offered to patients in all age groups: infants, children, and adults. The operation is palliative, and the need for reintervention (percutaneous or surgical) over a lifetime is inevitable for the majority of patients. This study represents the largest reported series of patients undergoing reoperation after the Ross procedure to date. Although literature is available that quantifies the incidence of reoperation after the Ross procedure, there are no published reports that address the qualitative nature and risks associated with reoperation when it is required. This manuscript provides that "missing" information so the clinician can properly counsel patients not only about the potential need for reoperation but also about the nature of the reoperation when it is necessary. See p 1153.
Scimitar Syndrome: A European Congenital Heart Surgeons Association (ECHSA) Multicentric Study
Scimitar syndrome is a rare association of congenital cardiopulmonary anomalies that has been reported in 3% to 6% of patients with partial anomalous venous connection. To analyze the surgical results and follow-up outcome of patients who underwent surgery for scimitar syndrome, we embarked on an European Congenital Heart Surgeons Association (ECHSA) multicentric data collection in a relatively recent time period. Our data indicate that scimitar syndrome is not a simple and benign congenital heart disease and that it is often associated with other cardiac anomalies that play an important role in the long-term results. The majority of our patients presented with preoperative symptoms that represent one of the main indications for surgical repair, particularly when pulmonary arterial hypertension is present. We demonstrated that corrective surgery can be done safely with a low mortality and morbidity rate, which are independent of the type of corrective surgical technique used. Patients who underwent a right pneumectomy had severe right lung hypoplasia and showed a more severe degree of preoperative respiratory symptoms, congestive heart failure, and pulmonary arterial hypertension, which was also consistent with their higher incidence of postoperative mortality and morbidity. Of note also is the fact that the presence of pulmonary arterial hypertension is associated with a higher mortality rate. At the latest clinical control, the majority of patients were asymptomatic; however, we found a relatively high incidence of residual scimitar drainage stenosis (15.5%) requiring reoperation or hemodynamic reintervention, which is similar in the 2 reported surgical techniques. See p 1159.
Attained Educational Level and Incident Atherothrombotic Events in Low-and Middle-Income Compared With High-Income Countries
Atherothrombotic diseases (coronary heart disease, cerebrovascular disease, and peripheral arterial disease) are the leading cause of death worldwide. Attained educational level is a socioeconomic indicator that strongly predicts cardiovascular outcomes. However, most studies reporting this association have been conducted in highincome countries (HICs), with very little representation from lowand middle-income countries (LMICs), which bear Ͼ80% of the world's cardiovascular deaths. In the global Reduction of Atherothrombosis for Continued Health (REACH) Registry, 61 332 clinic outpatients with either established atherothrombotic disease or multiple atherothrombotic risk factors were recruited from 44 countries from both LMIC and HIC regions. Self-reported attained educational level (the number of years of formal education completed) and cardiovascular risk factors were documented at baseline, and patients were followed up longitudinally for 23 months for incident atherothrombotic events. Educational attainment was inversely associated with age and diabetes mellitus and directly associated with hypercholesterolemia in all subjects. However, for other risk factors such as obesity, smoking, hypertension, and baseline burden of vascular disease, attained educational level was protective (inversely associated) in HICs but not protective in LMICs. The protective association between higher attained educational level and incident cardiovascular events was strongest in men from HICs, more modest in men from LMICs and in women from HICs, and essentially absent in women from LMICs. These results indicate that studies that report a protective association between attained educational level and cardiovascular outcomes in HICs do not extrapolate to LMICs, especially in women. Further studies dedicated to LMIC settings are essential to investigate the association between socioeconomic indicators and cardiovascular outcomes in these regions. See p 1167.
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Association of Colony-Forming Units With Coronary Artery and Abdominal Aortic Calcification
Endothelial progenitor cells are made up of circulating cells that originate from the bone marrow and are believed to contribute to arterial homeostasis. Although experimental studies suggest that decreased endothelial progenitor cell quantity may promote atherosclerosis, data in humans are limited. Therefore, among 889 participants of the Framingham Heart Study, we examined the association of endothelial progenitor cell-related cell types with the presence of subclinical atherosclerosis as evidenced by coronary artery calcification or abdominal aortic calcification detected by multidetector computed tomography. We observed that a lower quantity of colony-forming units was significantly associated with greater coronary artery calcification and abdominal aortic calcification, even after adjustment for cardiovascular risk factors. In contrast, neither the CD34 ϩ /KDR ϩ nor CD34 ϩ cell type was associated with differences in coronary artery calcification or abdominal aortic calcification. These results are consistent with the theory that colony-forming units and CD34 ϩ -related cells represent different functional types of endothelial progenitor cells, with likely distinct roles in mediating the vascular response to atherogenic exposures. Overall, these findings suggest that decreased angiogenic potential, as represented by colony-forming unit quantity, could contribute to the development of atherosclerosis in humans. See p 1176.
Multicenter Cluster-Randomized Trial of a Multifactorial Intervention to Improve Antihypertensive Medication Adherence and Blood Pressure Control Among Patients at High Cardiovascular Risk (The COM99 Study)
Nonadherence to antihypertensive medication is prevalent in clinical practice; however, the prevalence of nonadherence to antihypertensive medication might not be as high in Western societies as previously thought. In this study, we found high rates of adherence in both the control and the intervention group. Although electronic measurement of adherence may have introduced a Hawthorne effect in our study (and thereby promoted adherence in both groups), recent studies using other methods of measuring adherence have also found high rates of adherence to antihypertensive medication. This multifactorial adherence intervention had 3 main components: (1) The counting of pills during physician visits, (2) designation of a family member to support adherence behavior, and (3) provision of an information sheet to patients that included information on each antihypertensive medication dose and frequency, potential medication side effects, and how the medication was to be taken. Patients in the intervention group had small but significant improvements in both adherence and blood pressure control. No effects were found on cardiovascular morbidity and mortality, but the study was not sufficiently powered for these outcomes. Although the intervention was designed to be feasible in clinical practice (ie, simple and inexpensive to implement), it did increase the average length of an office visit by Ϸ7 minutes. Although this amount of time might be prohibitive in some busy clinical settings, it did appear sufficient to improve patient adherence, which is often considered an intransigent problem. Perhaps future interventions can also involve other clinical professionals who can provide additional time and focus on patient medication adherence. See p 1183.
Preeclampsia and Gestational Hypertension Are Associated With Childhood Blood Pressure Independently of Family Adiposity Measures: The Avon Longitudinal Study of Parents and Children
Offspring of women with hypertensive disorders of pregnancy are at increased risk of cardiovascular complications later in life, but the mechanisms underlying these associations are unclear. Using data from 6343 mother-offspring pairs enrolled in a UK birth cohort, we examined differences in associations between preeclampsia and gestational hypertension with offspring blood pressure measured at 9 to 10 years of age and the role that birth weight and parental and offspring adiposity might have in explaining any associations. Both preeclampsia and gestational hypertension were associated with systolic and diastolic blood pressures in the offspring. These associations were similar in magnitude for the 2 exposures and were not explained by parental or own adiposity. After adjustment for parental and own adiposity and for other potential confounders, there was a mean difference in systolic blood pressure of 2.05 mm Hg (95% confidence interval, 0.72 to 3.38) and 2.04 mm Hg (95% confidence interval, 1.42 to 2.67) for preeclampsia and gestational hypertension, respectively, compared with those with no hypertensive disorders of pregnancy. Equivalent results for diastolic blood pressure were 1.00 mm Hg (95% confidence interval, Ϫ0.01 to 2.10) and 1.07 mm Hg (95% confidence interval, 0.60 to 1.54). The association of preeclampsia with offspring systolic and diastolic blood pressures attenuated to the null with further adjustment for birth weight and gestational age, whereas these adjustments did not attenuate the association of gestational hypertension with offspring blood pressure. Our findings suggest that the relationship between gestational hypertension and offspring blood pressure might reflect shared genetic or familial environmental characteristics (unrelated to familial adiposity) but that the relationship between preeclampsia and offspring blood pressure is driven largely by intrauterine characteristics. See p 1192.
Genetic Deficiency of Plasminogen Activator Inhibitor-1 Promotes Cardiac Fibrosis in Aged Mice: Involvement of Constitutive Transforming Growth Factor-␤ Signaling and Endothelial-to-Mesenchymal Transition
Cardiac fibrosis, defined as the proliferation of interstitial fibroblasts and accumulation of extracellular matrix components in the heart, is a common consequence of cardiovascular disease, including acute myocardial infarction and hypertension. Cardiac fibrosis contributes to the development of ventricular dysfunction (systolic and diastolic), heart failure, and arrhythmias. Although fibrosis is predictably identified in end-stage heart disease, the origin of fibroblasts contributing to the excessive synthesis of collagen in the fibrotic heart is controversial. At present, there is no effective treatment to prevent or to reverse cardiac fibrosis. The present study elucidates the molecular basis of cardiac fibrosis using a murine model of age-dependent spontaneous cardiac fibrosis that develops in the absence of the plasminogen activator inhibitor-1 gene. The present study suggests that the cardiac fibrosis in plasminogen activator inhibitor-1-deficient mice is due to increased inflammation, elevated levels of transforming growth factor-␤, and induction of transforming growth factor-␤induced profibrotic responses. Plasminogen activator inhibitor-1deficient endothelial cells appear to be more susceptible to the phenomenon called endothelial-mesenchymal transition in response to transforming growth factor-␤ via induction of both Smad and ERK1/2 MAPK pathways. These findings provide new insights into molecular mechanisms of cardiac fibrosis and suggest that physiological plasminogen activator inhibitor-1 levels help to protect the heart from age-dependent fibrogenesis. Thus, specific disruption of activated Smad and ERK1/2 MAPK signaling pathways with smallmolecule inhibitor(s) may be useful in limiting endothelialmesenchymal transition and may inform a novel therapeutic approach to prevent and treat cardiac fibrosis in humans. See p 1200.
